Biosensia
Biosensia developed RapiPlex, a point-of-care diagnosis system based on proprietary technologies capable of producing quantitative and qualitative laboratory quality test results.
Biosensia merged with Kypha in 2018, a USA based in-vitro diagnostics company, to co-develop immune and inflammation assays on the Biosensia point-of-care RapiPlex platform.